chr6-41033905-C-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_173561.3(UNC5CL):āc.662G>Cā(p.Cys221Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00143 in 1,613,662 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00084 ( 0 hom., cov: 33)
Exomes š: 0.0015 ( 2 hom. )
Consequence
UNC5CL
NM_173561.3 missense
NM_173561.3 missense
Scores
4
6
9
Clinical Significance
Conservation
PhyloP100: 3.86
Genes affected
UNC5CL (HGNC:21203): (unc-5 family C-terminal like) Enables peptidase activity. Acts upstream of or within positive regulation of I-kappaB kinase/NF-kappaB signaling and positive regulation of JNK cascade. Located in membrane. [provided by Alliance of Genome Resources, Apr 2022]
OARD1 (HGNC:21257): (O-acyl-ADP-ribose deacylase 1) The protein encoded by this gene is a deacylase that can convert O-acetyl-ADP-ribose to ADP-ribose and acetate, O-propionyl-ADP-ribose to ADP-ribose and propionate, and O-butyryl-ADP-ribose to ADP-ribose and butyrate. The ADP-ribose product is able to inhibit these reactions through a competitive feedback loop. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.35303038).
BS2
High Homozygotes in GnomAdExome4 at 2 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UNC5CL | NM_173561.3 | c.662G>C | p.Cys221Ser | missense_variant | 3/9 | ENST00000244565.8 | NP_775832.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UNC5CL | ENST00000244565.8 | c.662G>C | p.Cys221Ser | missense_variant | 3/9 | 1 | NM_173561.3 | ENSP00000244565 | P1 | |
UNC5CL | ENST00000373164.1 | c.662G>C | p.Cys221Ser | missense_variant | 2/8 | 1 | ENSP00000362258 | P1 | ||
OARD1 | ENST00000482853.5 | c.*735G>C | 3_prime_UTR_variant, NMD_transcript_variant | 5/5 | 2 | ENSP00000420472 |
Frequencies
GnomAD3 genomes AF: 0.000841 AC: 128AN: 152184Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
128
AN:
152184
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000742 AC: 185AN: 249278Hom.: 0 AF XY: 0.000703 AC XY: 95AN XY: 135068
GnomAD3 exomes
AF:
AC:
185
AN:
249278
Hom.:
AF XY:
AC XY:
95
AN XY:
135068
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00149 AC: 2182AN: 1461360Hom.: 2 Cov.: 31 AF XY: 0.00144 AC XY: 1046AN XY: 726958
GnomAD4 exome
AF:
AC:
2182
AN:
1461360
Hom.:
Cov.:
31
AF XY:
AC XY:
1046
AN XY:
726958
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000840 AC: 128AN: 152302Hom.: 0 Cov.: 33 AF XY: 0.000685 AC XY: 51AN XY: 74480
GnomAD4 genome
AF:
AC:
128
AN:
152302
Hom.:
Cov.:
33
AF XY:
AC XY:
51
AN XY:
74480
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
11
ALSPAC
AF:
AC:
11
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
14
ExAC
AF:
AC:
85
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 22, 2021 | The c.662G>C (p.C221S) alteration is located in exon 3 (coding exon 2) of the UNC5CL gene. This alteration results from a G to C substitution at nucleotide position 662, causing the cysteine (C) at amino acid position 221 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;.
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D
REVEL
Uncertain
Sift
Pathogenic
D;D
Sift4G
Pathogenic
D;D
Polyphen
D;D
Vest4
MutPred
Gain of disorder (P = 7e-04);Gain of disorder (P = 7e-04);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at